Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung...
Vous n'êtes pas connecté
Brigham and Women's Hospital researchers have developed a promising "dual action" treatment for lung cancer that combines immunotherapy with targeted
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung...
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers....
New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...
A new study led by researchers at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, suggests that using...
Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother's own body. A Kobe...
A combined team of bio researchers and roboticists from Brigham and Women's Hospital, in the U.S., and the iPrint Institute, in Switzerland, has...
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and cervical cancers (2) who gain clinically meaningful benefit...
Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia, a common condition related to...
THURSDAY, Sept. 26, 2024 -- Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other...
Non-smokers found to have 1% chance of treatment leading to disease compared with between 2% and 6% for smokers